TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Binab Bio-Innovation AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
681
|
747
|
837 |
| Financial expenses |
16
|
1
|
3 |
| Earnings before taxes |
6
|
-14
|
19 |
| EBITDA |
37
|
10
|
59 |
| Total assets |
324
|
341
|
473 |
| Current assets |
221
|
231
|
335 |
| Current liabilities |
93
|
131
|
240 |
| Equity capital |
230
|
209
|
230 |
| - share capital |
101
|
95
|
98 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
71.0%
|
61.3%
|
48.6% |
| Turnover per employee |
681
|
747
|
837 |
| Profit as a percentage of turnover |
0.9%
|
-1.9%
|
2.3% |
| Return on assets (ROA) |
6.8%
|
-3.8%
|
4.7% |
| Current ratio |
237.6%
|
176.3%
|
139.6% |
| Return on equity (ROE) |
2.6%
|
-6.7%
|
8.3% |
| Change turnover |
-120
|
-64
|
123 |
| Change turnover % |
-15%
|
-8%
|
17% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.